...BRCA1-A DNA damage repair complex, as an Akt substrate that is phosphorylated following doxorubicin treatment. MERIT40 p...
...BRCA1/2 mutations have been reported to date and the BRCA1/2 de novo mutation rate remains unknown. The present study wa...
...BRCA1 and BRCA2 testing was performed in a routine diagnostic setting. The prevalence of the BRCA1 stop mutation c.4183C...
...BRCA1/2 mutation carriers (summary RR = 0.56, 95 % CI = 0.41-0.76). Similar findings were observed in BRCA1 mutation car...
...BRCA1 mutation, compared to 4.5 % for a mutation carrier with three such relatives. This contrast illustrates the value ...
...BRCA1 and H2AX. In the present study, a two-dimensional electrophoresis (2DE) proteomic approach was employed to identif...
...BRCA1 or BRCA2 mutations have documented a pre-metastatic intramucosal neoplasm that is found almost exclusively in the ...
...BRCA1 and BRCA2 mutation carriers. miRNA profiles of 17 BRCA1- and 9 BRCA2-associated breast carcinomas were analyzed us...
...BRCA1 positivity generated considerable media attention. To the authors' knowledge, the current study is the first prosp...
...BRCA1 associated with any complex trait. Mendelian randomization analyses supported a causal effect of later ANM on brea...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
